Literature DB >> 19735186

Anti-obesity effects of xanthohumol plus guggulsterone in 3T3-L1 adipocytes.

Srujana Rayalam1, Jeong-Yeh Yang, Mary Anne Della-Fera, Hea Jin Park, Suresh Ambati, Clifton A Baile.   

Abstract

Xanthohumol (XN) and guggulsterone (GS) have each been shown to inhibit adipogenesis and induce apoptosis in adipocytes. In the present study effects of the combination of XN + GS on 3T3-L1 adipocyte apoptosis and adipogenesis were investigated. Mature adipocytes were treated with XN and GS individually and in combination. XN and GS individually decreased cell viability, but XN + GS caused an enhanced decrease in viability and potentiated induction of apoptosis. Likewise, XN + GS caused a potentiated increase in caspase-3/7 activation, whereas neither of the compounds showed any effect individually. In addition, western blot analysis revealed that XN + GS increased Bax expression and decreased Bcl-2 expression, whereas individual compounds did not show any significant effect. XN and GS both decreased lipid accumulation. Individually, XN at 1.5 microM and GS at 3.12 microM decreased lipid accumulation by 26 +/- 4.5% (P < .001) each, whereas XN1.5 + GS3.12 decreased lipid accumulation by 78.2 +/- 1.8% (P < .001). Moreover, expression of the adipocyte-specific proteins was down-regulated with XN1.5 + GS3.12, but no effect was observed with the individual compounds. Finally, XN + GS caused an enhanced stimulation of lipolysis. Thus, combination of XN and GS is more potent in exerting anti-obesity effects than additive effects of the individual compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19735186     DOI: 10.1089/jmf.2008.0158

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  7 in total

1.  Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration.

Authors:  LeeCole Legette; Lian Ma; Ralph L Reed; Cristobal L Miranda; John Mark Christensen; Rosita Rodriguez-Proteau; Jan F Stevens
Journal:  Mol Nutr Food Res       Date:  2011-12-07       Impact factor: 5.914

2.  The combination of resveratrol and conjugated linoleic acid attenuates the individual effects of these molecules on triacylglycerol metabolism in adipose tissue.

Authors:  N Arias; J Miranda; M T Macarulla; L Aguirre; A Fernández-Quintela; C Andres-Lacueva; M Urpi-Sarda; M P Portillo
Journal:  Eur J Nutr       Date:  2013-07-30       Impact factor: 5.614

Review 3.  Phytochemicals as novel agents for the induction of browning in white adipose tissue.

Authors:  Yusra Azhar; Ashish Parmar; Colette N Miller; Janaiya S Samuels; Srujana Rayalam
Journal:  Nutr Metab (Lond)       Date:  2016-12-03       Impact factor: 4.169

4.  Sulforaphane and myricetin act synergistically to induce apoptosis in 3T3‑L1 adipocytes.

Authors:  Anjun Yao; Yingzhuo Shen; Zhuangwei Zhang; Zuquan Zou; Anshi Wang; Shiyong Chen; Huiqin Zhang; Fen Chen; Jinshun Zhao; Zhongming Chen; Yujuan Shan; Xiaohong Zhang
Journal:  Mol Med Rep       Date:  2017-12-11       Impact factor: 2.952

5.  Modulation of Adipocyte Differentiation and Proadipogenic Gene Expression by Sulforaphane, Genistein, and Docosahexaenoic Acid as a First Step to Counteract Obesity.

Authors:  Veronica Valli; Katharina Heilmann; Francesca Danesi; Alessandra Bordoni; Clarissa Gerhäuser
Journal:  Oxid Med Cell Longev       Date:  2018-02-07       Impact factor: 6.543

6.  Novel anti-obesity effects of beer hops compound xanthohumol: role of AMPK signaling pathway.

Authors:  Janaiya S Samuels; Rangaiah Shashidharamurthy; Srujana Rayalam
Journal:  Nutr Metab (Lond)       Date:  2018-06-15       Impact factor: 4.169

7.  Screening for anti-adipogenic, pro-lipolytic and thermogenic plant extracts by models associating intestinal epithelial cells with human adipose cells.

Authors:  Damien Guillemet; Chloé Belles; Aurélie Gomes; Vincent Azalbert; Mathilde André; Nourdine Faresse; Rémy Burcelin; Jean-Michel Lagarde; Danièle Lacasa; Mayoura Kéophiphath
Journal:  Eur J Nutr       Date:  2022-01-29       Impact factor: 4.865

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.